Abstract: A system for facilitating efficient port reconfiguration at a switch is provided. During operation, the system can identify a target port of the switch for reconfiguration based on one or more reconfiguration parameters indicating how a set of logical ports are generated from the target port. The system can disable the target port at the control plane of the switch, which disables features provided to the target port from the control plane. The control plane can provide a set of features supported by the switch at a port-level granularity for facilitating operations of the switch. The system can then configure the forwarding hardware based on the reconfiguration parameters to accommodate the set of logical ports. When the reconfiguration of the target port is complete, the system can enable a respective logical port at the control plane, which enables one or more features for the logical port from the control plane.

Abstract: A method for the execution of implants, surface finishes of implants the manufacture of a particulated bone material, and with the particulated bone material obtained, a method for the manufacture of a bone-biopolymer filament may be performed, to obtain a bone-biopolymer filament. The filament may be used, for example, in a method for the manufacture of implants by 3D-printing. A method for the manufacture of bone implants by machining; once a bone implant has been obtained by the method of manufacture of implants by 3D-printing or the method of manufacture of bone implants by machining, it is subjected to a texturisation to enable the osseointegration thereof.

Abstract: The present invention relates to polynucleotides encoding Streptococcus group C and G polypeptides and their use in immunogenic compositions. The invention also relates to immunogenic compositions comprising polypeptides encoded by those polynucleotides. In addition, the invention relates to methods of inducing an immune response in mammals against beta hemolytic Streptococcus or beta hemolytic Streptococcus infection using immunogenic compositions of the Streptococcus group C and G polypeptides and polynucleotides.

Abstract: The present invention relates to polynucleotides encoding Streptococcus group C and G polypeptides and their use in immunogenic compositions. The invention also relates to immunogenic compositions comprising polypeptides encoded by those polynucleotides. In addition, the invention relates to methods of inducing an immune response in mammals against beta hemolytic Streptococcus or beta hemolytic Streptococcus infection using immunogenic compositions of the Streptococcus group C and G polypeptides and polynucleotides.

Abstract: The present invention relates to polynucleotides encoding Streptococcus group C and G polypeptides and their use in immunogenic compositions. The invention also relates to immunogenic compositions comprising polypeptides encoded by those polynucleotides. In addition, the invention relates to methods of inducing an immune response in mammals against beta hemolytic Streptococcus or beta hemolytic Streptococcus infection using immunogenic compositions of the Streptococcus group C and G polypeptides and polynucleotides.

Abstract: The present invention relates to compositions and methods of use comprising peptidyl-prolyl isomerase (PPI) polypeptides of group C and G streptococci and polynucleotides encoding same. The invention also relates to immunogenic compositions comprising the PPI polypeptides and polynucleotides, as well as antibodies and antibody fragments that bind the PPI polypeptides. In addition, the invention relates to methods of inducing an immune response in a subject against beta hemolytic streptococci using the immunogenic compositions, as well as conferring passive immunity by administering a therapeutic antibody or antibody fragment.

Abstract: A number of ?-hemolytic streptococci polynucleotides and polypeptides, particularly Streptococcus pyogenes polypeptides and polynucleotides, are described. Two or more of the polypeptides of the invention can be formulated for use as immunogenic compositions. Also disclosed are methods for immunizing against and reducing infection caused by ?-hemolytic streptococci.

Abstract: The present invention relates to polynucleotides encoding Streptococcus group C and G polypeptides and their use in immunogenic compositions. The invention also relates to immunogenic compositions comprising polypeptides encoded by those polynucleotides. In addition, the invention relates to methods of inducing an immune response in mammals against beta hemolytic Streptococcus or beta hemolytic Streptococcus infection using immunogenic compositions of the Streptococcus group C and G polypeptides and polynucleotides.

Abstract: The present invention relates to compositions and methods of use comprising peptidyl-prolyl isomerase (PPI) polypeptides of group C and G streptococci and polynucleotides encoding same. The invention also relates to immunogenic compositions comprising the PPI polypeptides and polynucleotides, as well as antibodies and antibody fragments that bind the PPI polypeptides. In addition, the invention relates to methods of inducing an immune response in a subject against beta hemolytic streptococci using the immunogenic compositions, as well as conferring passive immunity by administering a therapeutic antibody or antibody fragment.

Abstract: A system and method of reducing or raising patient body temperature in an expedited yet safe, cost-effective, and convenient manner. The patient cooling system of the present invention includes a positive pressure device, a cooler for regulating the temperature of gas entering a patient's lungs, and temperature monitoring and controlling means.

Abstract: A system and method of reducing or raising patient body temperature in an expedited yet safe, cost-effective, and convenient manner. The patient cooling system of the present invention includes a positive pressure device, a cooler for regulating the temperature of gas entering a patient's lungs, and temperature monitoring and controlling means.